The UK has approved a fifth COVID-19 vaccine, developed by U.S. company Novavax, which offers up to 89% protection against COVID-19 illness.
The Medicines and Healthcare products Regulatory Agency has said it is safe as a first and second dose in adults.
Copyright © 2020 CGTN. Beijing ICP prepared NO.16065310-3